WO1998033514A1 - Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses - Google Patents
Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses Download PDFInfo
- Publication number
- WO1998033514A1 WO1998033514A1 PCT/JP1998/000371 JP9800371W WO9833514A1 WO 1998033514 A1 WO1998033514 A1 WO 1998033514A1 JP 9800371 W JP9800371 W JP 9800371W WO 9833514 A1 WO9833514 A1 WO 9833514A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- freeze
- factor human
- osteoinductive factor
- mannitol
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Physical Education & Sports Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
Claims
Priority Applications (19)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69831223T DE69831223T9 (de) | 1997-01-30 | 1998-01-29 | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 |
AU56791/98A AU737595B2 (en) | 1997-01-30 | 1998-01-29 | Lyophilized composition of bone morphogenetic factor human MP52 |
NZ336509A NZ336509A (en) | 1997-01-30 | 1998-01-29 | Freeze-dried composition of bone morphogenetic protein human MP52 |
JP53271798A JP4209948B2 (ja) | 1997-01-30 | 1998-01-29 | 骨誘導因子ヒトmp52凍結乾燥組成物 |
PL98334852A PL189381B1 (pl) | 1997-01-30 | 1998-01-29 | Rekonstytuowany MP52 oraz sposób wytwarzania rekonstytuowanego MP52 |
HU0002386A HU226554B1 (en) | 1997-01-30 | 1998-01-29 | Freeze-dried composition of bone morphogenetic protein human mp52 |
CA002278546A CA2278546C (en) | 1997-01-30 | 1998-01-29 | Freeze-dried composition of bone morphogenetic protein human mp52 |
SI9830798T SI0972520T1 (sl) | 1997-01-30 | 1998-01-29 | Liofiliziran sestavek humanega kostnega morfogenetskega proteina MP52 |
UA99084832A UA50811C2 (uk) | 1997-01-30 | 1998-01-29 | Ліофілізована композиція морфогенетичного фактора кістки, спосіб одержання ліофілізованої композиції морфогенетичного фактора кістки |
APAP/P/1999/001602A AP983A (en) | 1997-01-30 | 1998-01-29 | Freeze-dried composition of bone morphogenetic protein human MP52. |
AT98901044T ATE302021T1 (de) | 1997-01-30 | 1998-01-29 | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 |
DK98901044T DK0972520T3 (da) | 1997-01-30 | 1998-01-29 | Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 |
BRPI9807537-3A BR9807537B1 (pt) | 1997-01-30 | 1998-01-29 | composição liofilizada de fator humano morfogenético ósseo mp52, bem como processo para sua preparação. |
EP98901044A EP0972520B9 (en) | 1997-01-30 | 1998-01-29 | Freeze-dried composition of bone morphogenetic protein human mp52 |
IL13096798A IL130967A0 (en) | 1997-01-30 | 1998-01-29 | Freeze-dried composition of bone morphogenetic protein human mp52 |
KR1019997006833A KR100548107B1 (ko) | 1997-01-30 | 1998-01-29 | 뼈 유도 인자 인간 mp52 동결 건조 조성물 |
EA199900694A EA001579B1 (ru) | 1997-01-30 | 1998-01-29 | Лиофилизированная композиция морфогенетического фактора роста кости мр52 человека и способ её получения |
IL130967A IL130967A (en) | 1997-01-30 | 1999-07-15 | Freeze-dried preparation of human morphogenetic MP52 bone protein |
NO19993702A NO322334B1 (no) | 1997-01-30 | 1999-07-29 | Lyofilisert preparat av human benmorfogenetisk faktor MP52, og fremgangsmate for fremstilling av et lyofilisert preparat av human benmorfogenetisk faktor MP52 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/16349 | 1997-01-30 | ||
JP1634997 | 1997-01-30 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09355551 A-371-Of-International | 1999-09-21 | ||
US10/666,535 Continuation-In-Part US20040132653A1 (en) | 1997-01-30 | 2003-09-22 | Lyophilized composition of bone morphogenetic factor human MP52 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998033514A1 true WO1998033514A1 (fr) | 1998-08-06 |
Family
ID=11913900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1998/000371 WO1998033514A1 (fr) | 1997-01-30 | 1998-01-29 | Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0972520B9 (ja) |
JP (1) | JP4209948B2 (ja) |
KR (1) | KR100548107B1 (ja) |
CN (1) | CN1152712C (ja) |
AP (1) | AP983A (ja) |
AT (1) | ATE302021T1 (ja) |
AU (1) | AU737595B2 (ja) |
BR (1) | BR9807537B1 (ja) |
CA (1) | CA2278546C (ja) |
DE (1) | DE69831223T9 (ja) |
DK (1) | DK0972520T3 (ja) |
EA (1) | EA001579B1 (ja) |
ES (1) | ES2244043T3 (ja) |
HU (1) | HU226554B1 (ja) |
IL (2) | IL130967A0 (ja) |
NO (1) | NO322334B1 (ja) |
NZ (1) | NZ336509A (ja) |
PL (1) | PL189381B1 (ja) |
RS (1) | RS49691B (ja) |
SI (1) | SI0972520T1 (ja) |
TR (1) | TR199901832T2 (ja) |
WO (1) | WO1998033514A1 (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007501223A (ja) * | 2003-08-05 | 2007-01-25 | フジ フォト フィルム ビー.ブイ. | 安定剤としての組換え又は合成ゼラチンのワクチン中の使用 |
JP2007534633A (ja) * | 2003-11-10 | 2007-11-29 | アライバ−プロメティック インコーポレイティド | ヒト・アルファ1−抗トリプシン製剤 |
US7763270B2 (en) | 2002-09-10 | 2010-07-27 | Scil Technology Gmbh | Metal implant coated under reduced oxygen concentration with osteoinductive protein |
US8546334B2 (en) | 2001-11-19 | 2013-10-01 | Scil Technology Gmbh | Device having osteoinductive and osteoconductive properties |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998034655A1 (en) † | 1997-02-07 | 1998-08-13 | Stryker Corporation | Matrix-free osteogenic devices, implants and methods of use thereof |
WO2003030873A1 (en) * | 2001-10-09 | 2003-04-17 | Cellfactors Plc | Therapeutic biological product and method for formation of new vascularised bone |
JP4944010B2 (ja) | 2004-03-10 | 2012-05-30 | サイル テクノロジー ゲーエムベーハー | コーティングされたインプラント、その製造および使用 |
US10216709B2 (en) | 2015-05-22 | 2019-02-26 | Microsoft Technology Licensing, Llc | Unified messaging platform and interface for providing inline replies |
US20160344677A1 (en) | 2015-05-22 | 2016-11-24 | Microsoft Technology Licensing, Llc | Unified messaging platform for providing interactive semantic objects |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07503847A (ja) * | 1992-02-12 | 1995-04-27 | ビオファルム ゲゼルシャフト ツア ビオテヒノロ ギッシェン エントヴィックルング フォン ファル マカ ミット ベシュレンクテル ハフツング | 新規の増殖/分化因子をコード化するdna配列 |
WO1996033215A1 (fr) * | 1995-04-19 | 1996-10-24 | Hoechst Pharmaceuticals & Chemicals K.K. | Proteine nouvelle et son procede de fabrication |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0080879B1 (en) * | 1981-11-28 | 1986-10-01 | Sunstar Kabushiki Kaisha | Pharmaceutical composition containing interferon in stable state |
US5037644A (en) * | 1986-10-27 | 1991-08-06 | Cetus Corporation | Pharmaceutical compositions of recombinant interleukin-2 and formulation processes |
MX9203083A (es) * | 1991-06-21 | 1994-08-31 | Genetics Inst | Formulaciones farmaceuticas de proteinas osteogenicas. |
JP2966592B2 (ja) * | 1991-07-20 | 1999-10-25 | 萩原 義秀 | 安定化されたヒトモノクローナル抗体製剤 |
CA2093836A1 (en) * | 1992-04-24 | 1993-10-25 | Wayne Gombotz | Biodegradable tgf-.beta. delivery system for bone regeneration |
DE4239877C1 (de) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung |
KR100377967B1 (ko) * | 1995-03-21 | 2003-06-12 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | Hcg액상조성물 |
-
1998
- 1998-01-29 KR KR1019997006833A patent/KR100548107B1/ko not_active IP Right Cessation
- 1998-01-29 AT AT98901044T patent/ATE302021T1/de active
- 1998-01-29 AP APAP/P/1999/001602A patent/AP983A/en active
- 1998-01-29 EA EA199900694A patent/EA001579B1/ru not_active IP Right Cessation
- 1998-01-29 PL PL98334852A patent/PL189381B1/pl not_active IP Right Cessation
- 1998-01-29 NZ NZ336509A patent/NZ336509A/xx not_active IP Right Cessation
- 1998-01-29 CA CA002278546A patent/CA2278546C/en not_active Expired - Fee Related
- 1998-01-29 JP JP53271798A patent/JP4209948B2/ja not_active Expired - Fee Related
- 1998-01-29 ES ES98901044T patent/ES2244043T3/es not_active Expired - Lifetime
- 1998-01-29 DE DE69831223T patent/DE69831223T9/de active Active
- 1998-01-29 CN CNB988019841A patent/CN1152712C/zh not_active Expired - Fee Related
- 1998-01-29 WO PCT/JP1998/000371 patent/WO1998033514A1/ja active IP Right Grant
- 1998-01-29 TR TR1999/01832T patent/TR199901832T2/xx unknown
- 1998-01-29 RS YUP-349/99A patent/RS49691B/sr unknown
- 1998-01-29 EP EP98901044A patent/EP0972520B9/en not_active Expired - Lifetime
- 1998-01-29 HU HU0002386A patent/HU226554B1/hu not_active IP Right Cessation
- 1998-01-29 BR BRPI9807537-3A patent/BR9807537B1/pt not_active IP Right Cessation
- 1998-01-29 IL IL13096798A patent/IL130967A0/xx active IP Right Grant
- 1998-01-29 SI SI9830798T patent/SI0972520T1/sl unknown
- 1998-01-29 AU AU56791/98A patent/AU737595B2/en not_active Ceased
- 1998-01-29 DK DK98901044T patent/DK0972520T3/da active
-
1999
- 1999-07-15 IL IL130967A patent/IL130967A/en not_active IP Right Cessation
- 1999-07-29 NO NO19993702A patent/NO322334B1/no not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07503847A (ja) * | 1992-02-12 | 1995-04-27 | ビオファルム ゲゼルシャフト ツア ビオテヒノロ ギッシェン エントヴィックルング フォン ファル マカ ミット ベシュレンクテル ハフツング | 新規の増殖/分化因子をコード化するdna配列 |
WO1996033215A1 (fr) * | 1995-04-19 | 1996-10-24 | Hoechst Pharmaceuticals & Chemicals K.K. | Proteine nouvelle et son procede de fabrication |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8546334B2 (en) | 2001-11-19 | 2013-10-01 | Scil Technology Gmbh | Device having osteoinductive and osteoconductive properties |
US7763270B2 (en) | 2002-09-10 | 2010-07-27 | Scil Technology Gmbh | Metal implant coated under reduced oxygen concentration with osteoinductive protein |
US8257728B2 (en) | 2002-09-10 | 2012-09-04 | Scil Technology Gmbh | Metal implant coated under reduced oxygen concentration with osteoinductive protein |
JP2007501223A (ja) * | 2003-08-05 | 2007-01-25 | フジ フォト フィルム ビー.ブイ. | 安定剤としての組換え又は合成ゼラチンのワクチン中の使用 |
JP2007534633A (ja) * | 2003-11-10 | 2007-11-29 | アライバ−プロメティック インコーポレイティド | ヒト・アルファ1−抗トリプシン製剤 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR930000861B1 (ko) | 오메프라졸 직장투여 조성물 | |
CN101056623B (zh) | 稳定的头孢菌素衍生物冻干制剂 | |
TWI580443B (zh) | 地蓋瑞利(degarelix)之製備技術 | |
WO1998033514A1 (fr) | Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses | |
JPH11515002A (ja) | 副甲状腺ホルモンを含む安定な医薬投与形態 | |
CA2311754C (en) | A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5 ml | |
JPS635028A (ja) | 凍結乾燥医薬組成物 | |
US20040132653A1 (en) | Lyophilized composition of bone morphogenetic factor human MP52 | |
KR100725076B1 (ko) | N-[o-(p-피발로일옥시벤젠술포닐아미노)벤조일]글리신·모노나트륨염·4수화물 함유 용액 및 제제 | |
JP3792487B2 (ja) | レシチン化スーパーオキシドジスムターゼ含有医薬組成物 | |
WO2001000230A1 (fr) | Composition medicamenteuse contenant une superoxyde dismutase modifiee par lecithine | |
JP3501471B2 (ja) | カルシトニン類の安定化組成物および安定化法 | |
JP4880845B2 (ja) | Grf含有凍結乾燥薬剤組成物 | |
JP3956654B2 (ja) | N−[o−(p−ピバロイルオキシベンゼンスルホニルアミノ)ベンゾイル]グリシン・モノナトリウム塩・4水和物含有溶液および製剤 | |
MXPA99006784A (en) | Freeze-dried composition of bone morphogenetic protein human mp52 | |
KR20120139299A (ko) | 표피세포성장인자를 함유하는 안정한 주사제용 동결건조 조성물 | |
EA044682B1 (ru) | Фармацевтическая композиция, содержащая ромиплостим | |
JPH0853365A (ja) | 経口用トロンビン製剤 | |
JPS63174928A (ja) | 注射用製剤 | |
UA50811C2 (uk) | Ліофілізована композиція морфогенетичного фактора кістки, спосіб одержання ліофілізованої композиції морфогенетичного фактора кістки | |
JPS62149623A (ja) | 安定なgrf製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 130967 Country of ref document: IL Ref document number: P-349/99 Country of ref document: YU Ref document number: 98801984.1 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998901044 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BA BB BG BR CA CN CU CZ EE GE GW HU ID IL IS JP KR LC LK LR LT LV MG MK MN MX NO NZ PL RO SG SI SK SL TR TT UA US UZ VN YU |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 336509 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/006784 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 2278546 Country of ref document: CA Ref document number: 2278546 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 56791/98 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019997006833 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999/01832 Country of ref document: TR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 199900694 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09355551 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1998901044 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997006833 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 56791/98 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998901044 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1019997006833 Country of ref document: KR |